Sterilisation service provider Mediscan, headquartered in Kremsmünster, is building another facility adjacent to the existing plant to sterilise medical products and food packaging and refine plastics and semiconductors. The new system is scheduled to go into operation in mid-2024. The investment volume of EUR 20 million includes the system technology, the new building with infrastructure, and an additional photovoltaic system.
State-of-the-art technology and expertise
The system technology used meets the latest standards. It has undergone further technological development compared with the previous model and once again combines two different treatment technologies in a single system. This means that individual product requirements can be met with the highest accuracy and quality.
“The sterilisation performance of Mediscan is an integral part of the production chain for many Greiner Bio-One products. We have a highly specialised and experienced team that ensures safe sterilisation to the highest standards", says Rainer Perneker, CEO of Greiner Bio-One International GmbH.
Further capacity expansion necessary
Since the last site expansion in 2015, the production volumes of Greiner Bio-One and the demand for sterilisation services have continued to increase. The availability of sterilisation is essential for the adjacent parent company Greiner Bio-One because this represents the last step in the production chain. Mediscan treats the manufactured medical devices before they are delivered to customers worldwide.
“With the newly created capacities, Mediscan in Kremsmünster is developing into the largest sterilisation site in Europe. The expansion will also create further capacities in order to meet the demand of new third-party customers", says Dr Markus Niederreiter, Managing Director Mediscan GmbH & Co KG.
Installation of another photovoltaic system
Mediscan commissioned a photovoltaic system back in 2021. With the new plant, another photovoltaic system will be installed in order to cover part of the high energy demand in the sterilisation operation with solar energy. As a result, Greiner Bio-One is one step closer to its goal of increasing the proportion of self-generated electricity to 1.5% of electricity consumption by 2025.
Commitment to the Upper Austria site
Also in the field of sterilisation services, the international market environment is characterised by sharp price increases and limited availability. This makes it all the more important for Greiner Bio-One to ensure this service for its products and thus the supply of its customers. The investment-intensive expansion in close proximity to the Group’s largest production site was therefore a sensible step and a clear commitment to the Kremsmünster headquarters.
++++
Mediscan GmbH & Co KG
Mediscan is a subsidiary of Greiner Bio-One International GmbH and is one of the leading suppliers in Europe in the field of sterilisation of medical products and food packaging and the functional improvement of plastics and semiconductors by means of ionising radiation. The company operates sites in Kremsmünster/Rohr and Seibersdorf and employs around 50 people.
Greiner Bio-One International GmbH
Greiner Bio-One specializes in the development, production and distribution of high-quality plastic laboratory products. The company is a technology partner for hospitals, laboratories, universities, research institutes, and the diagnostic, pharmaceutical and biotechnology industries. Greiner Bio-One is split into three divisions – Preanalytics, BioScience and Sterilization. As an Original Equipment Manufacturer (OEM), Greiner Bio-One provides individual solutions in the area of custom-made design developments and production processes for the life sciences and medical sectors. In 2022, Greiner Bio-One International GmbH generated a turnover of 693 million euros and had 2,794 employees, 29 subsidiaries and numerous distribution partners in over 100 countries. Greiner Bio-One is part of Greiner AG, which is based in Kremsmünster (Austria).
